REPORT SCOPE & OVERVIEW
The Point of Care Lipid Test Market size was estimated USD 38.7 billion in 2022 and is expected to reach USD 65.5 billion by 2030 at a CAGR of 6.8% during the forecast period of 2023-2030.
Point of care lipid test are medical tests that help in the diagnosis of a condition in the human body at a precise moment. The point of care testing help to provide real-time results in minutes. As a result, a point of care (POC) lipid test is conducted to evaluate the lipid's activity in the cells. When cholesterol levels rise, the body's lipid function is disrupted, leading to significant ailments such as heart attack and coronary artery disease.
MARKET DYNAMICS
DRIVERS
A point-of-care (PoC) cholesterol test is gaining interest in the treatment of liver and kidney disorders.
Rising cases of chronic diseases such as liver and kidney disorders, as well as diabetes, are likely to drive the global point of care (PoC) lipid test market during the forecast period. Cardiovascular disease (CVD) is the major cause of death in chronic renal disease patients. One of the most prominent pathophysiological causes for CVD in CKD patients is the widespread and probably enhanced production of atherosclerotic plaques due to hyperlipidemia, uremic toxins, inflammation, and endothelial dysfunction. Chronic kidney disease (CKD) affects more than one out of every seven adults in the United States, or over 37 million people, according to the US Department of Health and Human Services. These are the variables that drive market expansion.
RESTRAIN
In some regions, there are no reimbursement policies for POC lipid tests.
In emerging economies, product availability is limited.
Issues with quality control linked with POC lipid testing devices.
OPPORTUNITY
Partnerships between diagnostic businesses and healthcare providers for efficient point-of-care testing.
Creation of novel POC lipid test technology with expanded capabilities.
Increasing need for technological advances
Rising need for technical developments that improve speed, accuracy, and usability, as well as rising market penetration rates for technologies such as self-testing handheld devices, are likely to fuel demand. Polymer Technology Systems Inc., for example, developed the CardioChek Plus analyzer in 2013, an upgraded version of their point-of-care multi-analyte device. Sedentary and unhealthy lifestyle choices are likely to supply manufacturers with a growing customer base.
CHALLENGES
High price
The rising cost of point-of-care (POC) cholesterol diagnostics will restrain market expansion. It has an additional cost of $2500.00. Furthermore, a lack of lab services in rural areas, particularly in developing countries, would stymie market growth. The scarcity of trained personnel in these domains would further hinder market growth prospects.
IMPACT OF RUSSIAN UKRAINE WAR
The war has significantly increased psychological pain and distress. According to health care professionals around the country, the most common request right now is for help with sleeplessness, anxiety, mourning, and psychological distress. WHO has increased staff and repurposed infrastructure, particularly the logistics system, in response to changing health demands in Ukraine. This has allowed for the delivery of over 543 metric tonnes of medical supplies and equipment to the country, which are being distributed mostly in the east, south, and northern oblasts where the need is highest. Among the materials sent are trauma surgical supplies, ambulances, Ukrainian-made ventilators that can continue to work even when power is down, electric generators, and oxygen equipment, including the construction of oxygen plants.
IMPACT OF ONGOING RECESSION
Three years after the pandemic immobilized the world, its aftermath continues to send the world into a frenzy as the recession siren becomes louder with each passing day. Several businesses, particularly scientific research, are concerned about the current recession warning. The pandemic has reduced the number of new programs and shifted financing to virology and vaccine development. This has a negative impact on research outside of the field of virology and life sciences in general. With several countries in recession, economists forecast a slight recession this year as economic uncertainty grows. Despite the promise of a surge in research funding in 2023, the scientific community is concerned about the consequences of the recession on research financing.
KEY SEGMENTS
By Product
Glucose monitoring
Strips
Meters
Lancets
Cardiometabolic testing products
Cardiac marker testing products
hsTnl
BNP
D-dimer
CK-MB
Myoglobin
Others
Blood gas/electrolytes testing products
HBAIC testing products
Infectious disease testing products
Influenza testing products
HIV testing products
Hepatitis C testing products
Sexually transmitted disease (STD) testing products
Healthcare-associated infection (HAl) testing products
Respiratory infection testing products
Tropical disease testing products
Others
Coagulation testing products
PT/INR testing products
Activated clotting time (ACT/APTT) testing products
Pregnancy and fertility testing products
Pregnancy testing products
Fertility testing products
Tumor/cancer marker testing products
Cholesterol testing products
Hematology testing products
Drug-of-abuse (DoA) testing products
Fecal occult testing products
Urinalysis testing products
Others
In 2022, glucose monitoring segment is expected to held the highest market share during the forecast period due to the growing popularity of portable, highly convenient, and cost-effective POC glucose tests. Point-of-care blood glucose (BG) testing has grown in popularity over central laboratory testing due to its quick response time. Furthermore, blood glucose POCT eliminates post-analytical and pre-analytical factors that may have an impact on test analysis, such as transportation, multiple user handling, order verification, and delayed reporting, resulting in improved test analysis.
By Technology
Lateral flow assays
Dipsticks
Microfluidics
Molecular diagnostics
Immunoassays
Agglutination assays
Flow-through
Solid phase
Biosensors
In 2022, the Biosensors segment is expected to dominate the market growth during the forecast period. Biosensor technology has grown in popularity due to its capacity to give speedy, accurate, and on-site diagnostic information. As a result, healthcare providers may make quick and informed decisions, leading to better patient outcomes. Intricon, a manufacturer of smart miniaturized electronics-powered medical devices, created the new Biosensors Centre of Excellence in January 2023 to consolidate its biosensor device knowledge into a vertically connected organization for offering biosensor devices to the medical business.
By Prescription
OTC testing
Prescription-based testing
By Application
Cardio metabolic testing
Infectious disease testing
Nephrology testing
Drug-of-abuse testing
Blood glucose testing
Pregnancy testing
Cancer biomarker testing
Others
In 2022, the nephrology testing segment is expected to dominate the market growth during the forecast period owing to the increased frequency of renal failures and other related illnesses. According to a CDC analysis published in 2023, more than one out of every seven persons, or 35.6 million Americans, suffer from chronic renal disease. POCT in nephrology has resulted in faster and more reliable results, allowing for early interventions and tailored treatment plans. Furthermore, the portability and convenience of use of point-of-care testing equipment allows testing in remote and resource-constrained areas, improving patient outcomes and saving healthcare costs.
By End-use
Hospitals
Diagnostic centers
Research laboratories
Home-care settings
Others
.png)
REGIONAL ANALYSES
North America held a significant market share in 2022 due to Rising R&D investments and brisk private funding for healthcare infrastructure development are propelling the industry forward. Furthermore, various market competitors are concentrating on developing testing solutions that will provide early results, thereby improving the regional market picture. In May 2023, Sensible Diagnostics, a Los Angeles-based startup, produced a tiny, low-cost sample-to-answer system that can do PCR in 10 minutes, along with economical test cartridges, with the initial focus on infectious disease testing at the point of care.
Asia-Pacific is witness to expand fastest CAGR rate during the forecast period owing to the region's aging population and the increased need for point-of-care testing devices for patients. Furthermore, the region's rising chronic illness burden, combined with the increased emphasis of significant corporations in emerging markets such as China, Japan, and others, is increasing demand for and adoption of point-of-care (PoC) cholesterol test devices.
REGIONAL COVERAGE
North America
US
Canada
Mexico
Europe
Eastern Europe
Poland
Romania
Hungary
Turkey
Rest of Eastern Europe
Western Europe
Germany
France
UK
Italy
Spain
Netherlands
Switzerland
Austria
Rest of Western Europe
Asia Pacific
China
India
Japan
South Korea
Vietnam
Singapore
Australia
Rest of Asia Pacific
Middle East & Africa
Middle East
UAE
Egypt
Saudi Arabia
Qatar
Rest of Middle East
Africa
Nigeria
South Africa
Rest of Africa
Latin America
Brazil
Argentina
Colombia
Rest of Latin America
Key Players
The major key players are Vital Biosciences, Becton, Dickinson and Company, Abbott Laboratories, F. Hoffmann-La Roche, ACON Laboratories, Inc, BioMerieux SA, Bio-Rad Laboratories. Inc, HemoCue AB (Danaher Corporation), Dexcom, Inc, Medtronic Plc, Meridian Bioscience, Nova Biomedical, OraSure Technologies, Siemens Healthineers AG, and BioLytical Laboratories Inc., and Others.
Vital Biosciences-Company Financial Analysis
RECENT DEVELOPMENT
In July 2023, Vital Biosciences introduced VitalOne, a new point-of-care lab testing technology that allows clinicians to conduct tests, diagnose patients, and treat them all in a single visit.
In January 2022, in regions where the CE Mark is accepted, Roche launched the Cobas pulse system, which combines professional blood glucose control with mobile digital medical capabilities to improve patient care.
| Report Attributes | Details |
| Market Size in 2022 | US$ 38.7 Billion |
| Market Size by 2030 | US$ 65.5 Billion |
| CAGR | CAGR of 6.8 % From 2023 to 2030 |
| Base Year | 2022 |
| Forecast Period | 2023-2030 |
| Historical Data | 2019-2021 |
| Report Scope & Coverage | Market Size, Segments Analysis, Competitive Landscape, Regional Analysis, DROC & SWOT Analysis, Forecast Outlook |
| Key Segments | • By Product (Glucose monitoring, Cardiometabolic testing products, Infectious disease testing products, Coagulation testing products, Pregnancy and fertility testing products, Tumor/cancer marker testing products, Cholesterol testing products, Hematology testing products, Drug-of-abuse (DoA) testing products, Fecal occult testing products, Urinalysis testing products, Others) • By Technology (Lateral flow assays, Dipsticks, Microfluidics, Molecular diagnostics, Immunoassays, Agglutination assays, Flow-through, Solid phase, Biosensors) • By Prescription (OTC testing, Prescription-based testing) • By Application (Cardio metabolic testing, Infectious disease testing, Nephrology testing, Drug-of-abuse testing, Blood glucose testing, Pregnancy testing, Cancer biomarker testing, Others) • By End User (Hospitals, Diagnostic centers, Research laboratories, Home-care settings, Others) |
| Regional Analysis/Coverage | North America (US, Canada, Mexico), Europe (Eastern Europe [Poland, Romania, Hungary, Turkey, Rest of Eastern Europe] Western Europe] Germany, France, UK, Italy, Spain, Netherlands, Switzerland, Austria, Rest of Western Europe]), Asia Pacific (China, India, Japan, South Korea, Vietnam, Singapore, Australia, Rest of Asia Pacific), Middle East & Africa (Middle East [UAE, Egypt, Saudi Arabia, Qatar, Rest of Middle East], Africa [Nigeria, South Africa, Rest of Africa], Latin America (Brazil, Argentina, Colombia Rest of Latin America) |
| Company Profiles | Vital Biosciences, Becton, Dickinson and Company, Abbott Laboratories, F. Hoffmann-La Roche, ACON Laboratories, Inc, BioMerieux SA, Bio-Rad Laboratories. Inc, HemoCue AB (Danaher Corporation), Dexcom, Inc, Medtronic Plc, Meridian Bioscience, Nova Biomedical, OraSure Technologies, Siemens Healthineers AG, and BioLytical Laboratories Inc. |
| Key Drivers | • A point-of-care (PoC) cholesterol test is gaining interest in the treatment of liver and kidney disorders. |
| Market Restrain | • In some regions, there are no reimbursement policies for POC lipid tests. • In emerging economies, product availability is limited. • Issues with quality control linked with POC lipid testing devices. |
Ans: Point of Care Lipid Test Market is anticipated to expand by 6.8% from 2023 to 2030.
Ans: The expected growth rate of Care Lipid Test Market is USD 65.5 billion by 2030.
Ans: Point of Care Lipid Test Market size was valued at USD 38.7 billion in 2022
Ans: North America is dominating the market of Point of Care Lipid Test Market.
Ans: Partnerships between diagnostic businesses and healthcare providers for efficient point-of-care testing.
TABLE OF CONTENT
1. Introduction
1.1 Market Definition
1.2 Scope
1.3 Research Assumptions
2. Research Methodology
3. Market Dynamics
3.1 Drivers
3.2 Restraints
3.3 Opportunities
3.4 Challenges
4. Impact Analysis
4.1 Impact of the Russia-Ukraine War
4.2 Impact of Ongoing Recession
4.2.1 Introduction
4.2.2 Impact on major economies
4.2.2.1 US
4.2.2.2 Canada
4.2.2.3 Germany
4.2.2.4 France
4.2.2.5 United Kingdom
4.2.2.6 China
4.2.2.7 Japan
4.2.2.8 South Korea
4.2.2.9 Rest of the World
5. Value Chain Analysis
6. Porter’s 5 forces model
7. PEST Analysis
8. Point of Care Lipid Test Market Segmentation, By Product
8.1Glucose monitoring
8.1.1Strips
8.1.2Meters
8.1.3Lancets
8.2Cardiometabolic testing products
8.2.1Cardiac marker testing products
8.2.1.1BNP
8.2.1.2D-dimer
8.2.1.3CK-MB
8.2.1.4Myoglobin
8.2.1.5Others
8.2.2Blood gas/electrolytes testing products
8.2.3HBAIC testing products
8.3Infectious disease testing products
8.3.1Influenza testing products
8.3.2HIV testing products
8.3.3Hepatitis C testing products
8.3.4Sexually transmitted disease (STD) testing products
8.3.5Healthcare-associated infection (HAl) testing products
8.3.6Respiratory infection testing products
8.3.7Tropical disease testing products
8.3.8Others
8.4Coagulation testing products
8.4.1PT/INR testing products
8.4.2Activated clotting time (ACT/APTT) testing products
8.5Pregnancy and fertility testing products
8.5.1Pregnancy testing products
8.5.2Fertility testing products
8.6Tumor/cancer marker testing products
8.7Cholesterol testing products
8.8Hematology testing products
8.9Drug-of-abuse (DoA) testing products
8.10Fecal occult testing products
8.11Urinalysis testing products
8.12Others
9. Point of Care Lipid Test Market Segmentation, By Technology
9.1Lateral flow assays
9.2Dipsticks
9.3Microfluidics
9.4Molecular diagnostics
9.5Immunoassays
9.6Agglutination assays
9.7Flow-through
9.8Solid phase
9.9Biosensors
10.Point of Care Lipid Test Market Segmentation, By Prescription
10.1OTC testing
10.2Prescription-based testing
11. Point of Care Lipid Test Market Segmentation, By Application
11.1Cardio metabolic testing
11.2Infectious disease testing
11.3Nephrology testing
11.4Drug-of-abuse testing
11.5Blood glucose testing
11.6Pregnancy testing
11.7Cancer biomarker testing
11.8Others
12. Point of Care Lipid Test Market Segmentation, By End User
12.1Hospitals
12.2Diagnostic centers
12.3Research laboratories
12.4Home-care settings
12.5Others
13. Regional Analysis
13.1 Introduction
13.2 North America
13.2.1 North America Point of Care Lipid Test Market by Country
13.2.2 North America Point of Care Lipid Test Market by Product
13.2.3 North America Point of Care Lipid Test Market by Technology
13.2.4 North America Point of Care Lipid Test Market by Prescription
13.2.5 North America Point of Care Lipid Test Market by Application
13.2.6 North America Point of Care Lipid Test Market by End User
13.2.7 USA
13.2.7.1 USA Point of Care Lipid Test Market by Product
13.2.7.2 USA Point of Care Lipid Test Market by Technology
13.2.7.3 USA Point of Care Lipid Test Market by Prescription
13.2.7.4 USA Point of Care Lipid Test Market by Application
13.2.7.5 USA Point of Care Lipid Test Market by End User
13.2.8 Canada
13.2.8.1 Canada Point of Care Lipid Test Market by Product
13.2.8.2 Canada Point of Care Lipid Test Market by Technology
13.2.8.3 Canada Point of Care Lipid Test Market by Prescription
13.2.8.4 Canada Point of Care Lipid Test Market by Application
13.2.8.5 Canada Point of Care Lipid Test Market by End User
13.2.9 Mexico
13.2.9.1 Mexico Point of Care Lipid Test Market by Product
13.2.9.2 Mexico Point of Care Lipid Test Market by Technology
13.2.9.3 Mexico Point of Care Lipid Test Market by Prescription
13.2.9.4 Mexico Point of Care Lipid Test Market by Application
13.2.9.5 Mexico Point of Care Lipid Test Market by End User
13.3 Europe
13.3.1 Eastern Europe
13.3.1.1 Eastern Europe Point of Care Lipid Test Market by Country
13.3.1.2 Eastern Europe Point of Care Lipid Test Market by Product
13.3.1.3 Eastern Europe Point of Care Lipid Test Market by Technology
13.3.1.4 Eastern Europe Point of Care Lipid Test Market by Prescription
13.3.1.5 Eastern Europe Point of Care Lipid Test Market by Application
13.3.1.6 Eastern Europe Point of Care Lipid Test Market by End User
13.3.1.7 Poland
13.3.1.7.1 Poland Point of Care Lipid Test Market by Product
13.3.1.7.2 Poland Point of Care Lipid Test Market by Technology
13.3.1.7.3 Poland Point of Care Lipid Test Market by Prescription
13.3.1.7.4 Poland Point of Care Lipid Test Market by Application
13.3.1.7.5 Poland Point of Care Lipid Test Market by End User
13.3.1.8 Romania
13.3.1.8.1 Romania Point of Care Lipid Test Market by Product
13.3.1.8.2 Romania Point of Care Lipid Test Market by Technology
13.3.1.8.3 Romania Point of Care Lipid Test Market by Prescription
13.3.1.8.4 Romania Point of Care Lipid Test Market by Application
13.3.1.8.5 Romania Point of Care Lipid Test Market by End User
13.3.1.9 Hungary
13.3.1.9.1 Hungary Point of Care Lipid Test Market by Product
13.3.1.9.2 Hungary Point of Care Lipid Test Market by Technology
13.3.1.9.3 Hungary Point of Care Lipid Test Market by Prescription
13.3.1.9.4 Hungary Point of Care Lipid Test Market by Application
13.3.1.9.5 Hungary Point of Care Lipid Test Market by End User
13.3.1.10 Turkey
13.3.1.10.1 Turkey Point of Care Lipid Test Market by Product
13.3.1.10.2 Turkey Point of Care Lipid Test Market by Technology
13.3.1.10.3 Turkey Point of Care Lipid Test Market by Prescription
13.3.1.10.4 Turkey Point of Care Lipid Test Market by Application
13.3.1.10.5 Turkey Point of Care Lipid Test Market by End User
13.3.1.11 Rest of Eastern Europe
13.3.1.11.1 Rest of Eastern Europe Point of Care Lipid Test Market by Product
13.3.1.11.2 Rest of Eastern Europe Point of Care Lipid Test Market by Technology
13.3.1.11.3 Rest of Eastern Europe Point of Care Lipid Test Market by Prescription
13.3.1.11.4 Rest of Eastern Europe Point of Care Lipid Test Market by Application
13.3.1.11.5 Rest of Eastern Europe Point of Care Lipid Test Market by End User
13.3.2 Western Europe
13.3.2.1 Western Europe Point of Care Lipid Test Market by Country
13.3.2.2 Western Europe Point of Care Lipid Test Market by Product
13.3.2.3 Western Europe Point of Care Lipid Test Market by Technology
13.3.2.4 Western Europe Point of Care Lipid Test Market by Prescription
13.3.2.5 Western Europe Point of Care Lipid Test Market by Application
13.3.2.6 Western Europe Point of Care Lipid Test Market by End User
13.3.2.7 Germany
13.3.2.7.1 Germany Point of Care Lipid Test Market by Product
13.3.2.7.2 Germany Point of Care Lipid Test Market by Technology
13.3.2.7.3 Germany Point of Care Lipid Test Market by Prescription
13.3.2.7.4 Germany Point of Care Lipid Test Market by Application
13.3.2.7.5 Germany Point of Care Lipid Test Market by End User
13.3.2.8 France
13.3.2.8.1 France Point of Care Lipid Test Market by Product
13.3.2.8.2 France Point of Care Lipid Test Market by Technology
13.3.2.8.3 France Point of Care Lipid Test Market by Prescription
13.3.2.8.4 France Point of Care Lipid Test Market by Application
13.3.2.8.5 France Point of Care Lipid Test Market by End User
13.3.2.9 UK
13.3.2.9.1 UK Point of Care Lipid Test Market by Product
13.3.2.9.2 UK Point of Care Lipid Test Market by Technology
13.3.2.9.3 UK Point of Care Lipid Test Market by Prescription
13.3.2.9.4 UK Point of Care Lipid Test Market by Application
13.3.2.9.5 UK Point of Care Lipid Test Market by End User
13.3.2.10 Italy
13.3.2.10.1 Italy Point of Care Lipid Test Market by Product
13.3.2.10.2 Italy Point of Care Lipid Test Market by Technology
13.3.2.10.3 Italy Point of Care Lipid Test Market by Prescription
13.3.2.10.4 Italy Point of Care Lipid Test Market by Application
13.3.2.10.5 Italy Point of Care Lipid Test Market by End User
13.3.2.11 Spain
13.3.2.11.1 Spain Point of Care Lipid Test Market by Product
13.3.2.11.2 Spain Point of Care Lipid Test Market by Technology
13.3.2.11.3 Spain Point of Care Lipid Test Market by Prescription
13.3.2.11.4 Spain Point of Care Lipid Test Market by Application
13.3.2.11.5 Spain Point of Care Lipid Test Market by End User
13.3.2.12 The Netherlands
13.3.2.12.1 Netherlands Point of Care Lipid Test Market by Product
13.3.2.12.2 Netherlands Point of Care Lipid Test Market by Technology
13.3.2.12.3 Netherlands Point of Care Lipid Test Market by Prescription
13.3.2.12.4 Netherlands Point of Care Lipid Test Market by Application
13.3.2.12.5 Netherlands Point of Care Lipid Test Market by End User
13.3.2.13 Switzerland
13.3.2.13.1 Switzerland Point of Care Lipid Test Market by Product
13.3.2.13.2 Switzerland Point of Care Lipid Test Market by Technology
13.3.2.13.3 Switzerland Point of Care Lipid Test Market by Prescription
13.3.2.13.4 Switzerland Point of Care Lipid Test Market by Application
13.3.2.13.5 Switzerland Point of Care Lipid Test Market by End User
13.3.2.14 Austria
13.3.2.14.1 Austria Point of Care Lipid Test Market by Product
13.3.2.14.2 Austria Point of Care Lipid Test Market by Technology
13.3.2.14.3 Austria Point of Care Lipid Test Market by Prescription
13.3.2.14.4 Austria Point of Care Lipid Test Market by Application
13.3.2.14.5 Austria Point of Care Lipid Test Market by End User
13.3.2.15 Rest of Western Europe
13.3.2.15.1 Rest of Western Europe Point of Care Lipid Test Market by Product
13.3.2.15.2 Rest of Western Europe Point of Care Lipid Test Market by Technology
13.3.2.15.3 Rest of Western Europe Point of Care Lipid Test Market by Prescription
13.3.2.15.4 Rest of Western Europe Point of Care Lipid Test Market by Application
13.3.2.15.5 Rest of Western Europe Point of Care Lipid Test Market by End User
13.4 Asia-Pacific
13.4.1 Asia Pacific Point of Care Lipid Test Market by Country
13.4.2 Asia Pacific Point of Care Lipid Test Market by Product
13.4.3 Asia Pacific Point of Care Lipid Test Market by Technology
13.4.4 Asia Pacific Point of Care Lipid Test Market by Prescription
13.4.5 Asia Pacific Point of Care Lipid Test Market by Application
13.4.6 Asia Pacific Point of Care Lipid Test Market by End User
13.4.7 China
13.4.7.1 China Point of Care Lipid Test Market by Product
13.4.7.2 China Point of Care Lipid Test Market by Technology
13.4.7.3 China Point of Care Lipid Test Market by Prescription
13.4.7.4 China Point of Care Lipid Test Market by Application
13.4.7.5 China Point of Care Lipid Test Market by End User
13.4.8 India
13.4.8.1 India Point of Care Lipid Test Market by Product
13.4.8.2 India Point of Care Lipid Test Market by Technology
13.4.8.3 India Point of Care Lipid Test Market by Prescription
13.4.8.4 India Point of Care Lipid Test Market by Application
13.4.8.5 India Point of Care Lipid Test Market by End User
13.4.9 Japan
13.4.9.1 Japan Point of Care Lipid Test Market by Product
13.4.9.2 Japan Point of Care Lipid Test Market by Technology
13.4.9.3 Japan Point of Care Lipid Test Market by Prescription
13.4.9.4 Japan Point of Care Lipid Test Market by Application
13.4.9.5 Japan Point of Care Lipid Test Market by End User
13.4.10 South Korea
13.4.10.1 South Korea Point of Care Lipid Test Market by Product
13.4.10.2 South Korea Point of Care Lipid Test Market by Technology
13.4.10.3 South Korea Point of Care Lipid Test Market by Prescription
13.4.10.4 South Korea Point of Care Lipid Test Market by Application
13.4.10.5 South Korea Point of Care Lipid Test Market by End User
13.4.11 Vietnam
13.4.11.1 Vietnam Point of Care Lipid Test Market by Product
13.4.11.2 Vietnam Point of Care Lipid Test Market by Technology
13.4.11.3 Vietnam Point of Care Lipid Test Market by Prescription
13.4.11.4 Vietnam Point of Care Lipid Test Market by Application
13.4.11.5 Vietnam Point of Care Lipid Test Market by End User
13.4.12 Singapore
13.4.12.1 Singapore Point of Care Lipid Test Market by Product
13.4.12.2 Singapore Point of Care Lipid Test Market by Technology
13.4.12.3 Singapore Point of Care Lipid Test Market by Prescription
13.4.12.4 Singapore Point of Care Lipid Test Market by Application
13.4.12.5 Singapore Point of Care Lipid Test Market by End User
13.4.13 Australia
13.4.13.1 Australia Point of Care Lipid Test Market by Product
13.4.13.2 Australia Point of Care Lipid Test Market by Technology
13.4.13.3 Australia Point of Care Lipid Test Market by Prescription
13.4.13.4 Australia Point of Care Lipid Test Market by Application
13.4.13.5 Australia Point of Care Lipid Test Market by End User
13.4.14 Rest of Asia-Pacific
13.4.14.1 APAC Point of Care Lipid Test Market by Product
13.4.14.2 APAC Point of Care Lipid Test Market by Technology
13.4.14.3 APAC Point of Care Lipid Test Market by Prescription
13.4.14.4 APAC Point of Care Lipid Test Market by Application
13.4.14.5 APAC Point of Care Lipid Test Market by End User
13.5 The Middle East & Africa
13.5.1 Middle East
13.5.1.1 Middle East Point of Care Lipid Test Market By country
13.5.1.2 Middle East Point of Care Lipid Test Market by Product
13.5.1.3 Middle East Point of Care Lipid Test Market by Technology
13.5.1.4 Middle East Point of Care Lipid Test Market by Prescription
13.5.1.5 Middle East Point of Care Lipid Test Market by Application
13.5.1.6 Middle East Point of Care Lipid Test Market by End User
13.5.1.7 UAE
13.5.1.7.1 UAE Point of Care Lipid Test Market by Product
13.5.1.7.2 UAE Point of Care Lipid Test Market by Technology
13.5.1.7.3 UAE Point of Care Lipid Test Market by Prescription
13.5.1.7.4 UAE Point of Care Lipid Test Market by Application
13.5.1.7.5 UAE Point of Care Lipid Test Market by End User
13.5.1.8 Egypt
13.5.1.8.1 Egypt Point of Care Lipid Test Market by Product
13.5.1.8.2 Egypt Point of Care Lipid Test Market by Technology
13.5.1.8.3 Egypt Point of Care Lipid Test Market by Prescription
13.5.1.8.4 Egypt Point of Care Lipid Test Market by Application
13.5.1.8.5 Egypt Point of Care Lipid Test Market by End User
13.5.1.9 Saudi Arabia
13.5.1.9.1 Saudi Arabia Point of Care Lipid Test Market by Product
13.5.1.9.2 Saudi Arabia Point of Care Lipid Test Market by Technology
13.5.1.9.3 Saudi Arabia Point of Care Lipid Test Market by Prescription
13.5.1.9.4 Saudi Arabia Point of Care Lipid Test Market by Application
13.5.1.9.5 Saudi Arabia Point of Care Lipid Test Market by End User
13.5.1.10 Qatar
13.5.1.10.1 Qatar Point of Care Lipid Test Market by Product
13.5.1.10.2 Qatar Point of Care Lipid Test Market by Technology
13.5.1.10.3 Qatar Point of Care Lipid Test Market by Prescription
13.5.1.10.4 Qatar Point of Care Lipid Test Market by Application
13.5.1.10.5 Qatar Point of Care Lipid Test Market by End User
13.5.1.11 Rest of Middle East
13.5.1.11.1 Rest of Middle East Point of Care Lipid Test Market by Product
13.5.1.11.2 Rest of Middle East Point of Care Lipid Test Market by Technology
13.5.1.11.3 Rest of Middle East Point of Care Lipid Test Market by Prescription
13.5.1.11.4 Rest of Middle East Point of Care Lipid Test Market by Application
13.5.1.11.5 Rest of Middle East Point of Care Lipid Test Market by End User
13.5.2 Africa
13.5.2.1 Africa Point of Care Lipid Test Market by Country
13.5.2.2 Africa Point of Care Lipid Test Market by Product
13.5.2.3 Africa Point of Care Lipid Test Market by Technology
13.5.2.4 Africa Point of Care Lipid Test Market by Prescription
13.5.2.5 Africa Point of Care Lipid Test Market by Application
13.5.2.6 Africa Point of Care Lipid Test Market by End User
13.5.2.7 Nigeria
13.5.2.7.1 Nigeria Point of Care Lipid Test Market by Product
13.5.2.7.2 Nigeria Point of Care Lipid Test Market by Technology
13.5.2.7.3 Nigeria Point of Care Lipid Test Market by Prescription
13.5.2.7.4 Nigeria Point of Care Lipid Test Market by Application
13.5.2.7.5 Nigeria Point of Care Lipid Test Market by End User
13.5.2.8 South Africa
13.5.2.8.1 South Africa Point of Care Lipid Test Market by Product
13.5.2.8.2 South Africa Point of Care Lipid Test Market by Technology
13.5.2.8.3 South Africa Point of Care Lipid Test Market by Prescription
13.5.2.8.4 South Africa Point of Care Lipid Test Market by Application
13.5.2.8.5 South Africa Point of Care Lipid Test Market by End User
13.5.2.9 Rest of Africa
13.5.2.9.1 Rest of Africa Point of Care Lipid Test Market by Product
13.5.2.9.2 Rest of Africa Point of Care Lipid Test Market by Technology
13.5.2.9.3 Rest of Africa Point of Care Lipid Test Market by Prescription
13.5.2.9.4 Rest of Africa Point of Care Lipid Test Market by Application
13.5.2.9.5 Rest of Africa Point of Care Lipid Test Market by End User
13.6 Latin America
13.6.1 Latin America Point of Care Lipid Test Market by Country
13.6.2 Latin America Point of Care Lipid Test Market by Product
13.6.3 Latin America Point of Care Lipid Test Market by Technology
13.6.4 Latin America Point of Care Lipid Test Market by Prescription
13.6.5 Latin America Point of Care Lipid Test Market by Application
13.6.6 Latin America Point of Care Lipid Test Market by End User
13.6.7 Brazil
13.6.7.1 Brazil Point of Care Lipid Test Market by Product
13.6.7.2 Brazil Point of Care Lipid Test Market by Technology
13.6.7.3 Brazil Point of Care Lipid Test Market by Prescription
13.6.7.4 Brazil Point of Care Lipid Test Market by Application
13.6.7.5 Brazil Point of Care Lipid Test Market by End User
13.6.8 Argentina
13.6.8.1 Argentina Point of Care Lipid Test Market by Product
13.6.8.2 Argentina Point of Care Lipid Test Market by Technology
13.6.8.3 Argentina Point of Care Lipid Test Market by Prescription
13.6.8.4 Argentina Point of Care Lipid Test Market by Application
13.6.8.5 Argentina Point of Care Lipid Test Market by End User
13.6.9 Colombia
13.6.9.1 Colombia Point of Care Lipid Test Market by Product
13.6.9.2 Colombia Point of Care Lipid Test Market by Technology
13.6.9.3 Colombia Point of Care Lipid Test Market by Prescription
13.6.9.4 Colombia Point of Care Lipid Test Market by Application
13.6.9.5 Colombia Point of Care Lipid Test Market by End User
13.6.10 Rest of Latin America
13.6.10.1 Rest of Latin America Point of Care Lipid Test Market by Product
13.6.10.2 Rest of Latin America Point of Care Lipid Test Market by Technology
13.6.10.3 Rest of Latin America Point of Care Lipid Test Market by Prescription
13.6.10.4 Rest of Latin America Point of Care Lipid Test Market by Application
13.6.10.5 Rest of Latin America Point of Care Lipid Test Market by End User
14 Company Profile
14.1 Vital Biosciences
14.1.1Company Overview
14.1.2 Financials
14.1.3 Product/Services Offered
14.1.4 SWOT Analysis
14.1.5 The SNS View
14.2 Becton, Dickinson and Company
14.2.1Company Overview
14.2.2 Financials
14.2.3 Product/Services Offered
14.2.4 SWOT Analysis
14.2.5 The SNS View
14.3 Abbott Laboratories
14.3.1Company Overview
14.3.2 Financials
14.3.3 Product/Services Offered
14.3.4 SWOT Analysis
14.3.5 The SNS View
14.4 F. Hoffmann-La Roche
14.4.1Company Overview
14.4.2 Financials
14.4.3 Product/Services Offered
14.4.4 SWOT Analysis
14.4.5 The SNS View
14.5 ACON Laboratories, Inc
14.5.1Company Overview
14.5.2 Financials
14.5.3 Product/Services Offered
14.5.4 SWOT Analysis
14.5.5 The SNS View
14.6 BioMerieux SA
14.6.1Company Overview
14.6.2 Financials
14.6.3 Product/Services Offered
14.6.4 SWOT Analysis
14.6.5 The SNS View
14.7 Bio-Rad Laboratories Inc
14.7.1Company Overview
14.7.2 Financials
14.7.3 Product/Services Offered
14.7.4 SWOT Analysis
14.7.5 The SNS View
14.8 HemoCue AB (Danaher Corporation)
14.8.1Company Overview
14.8.2 Financials
14.8.3 Product/Services Offered
14.8.4 SWOT Analysis
14.8.5 The SNS View
14.9 Dexcom, Inc
14.9.1Company Overview
14.9.2 Financials
14.9.3 Product/Services Offered
14.9.4 SWOT Analysis
14.9.5 The SNS View
14.10 Medtronic Plc
14.10.1Company Overview
14.10.2 Financials
14.10.3 Product/Services Offered
14.10.4 SWOT Analysis
14.10.5 The SNS View
14.11 Meridian Bioscience
14.11.1Company Overview
14.11.2 Financials
14.11.3 Product/Services Offered
14.11.4 SWOT Analysis
14.11.5 The SNS View
14.12 Nova Biomedical
14.12.1Company Overview
14.12.2 Financials
14.12.3 Product/Services Offered
14.12.4 SWOT Analysis
14.12.5 The SNS View
14.13 OraSure Technologies
14.13.1Company Overview
14.13.2 Financials
14.13.3 Product/Services Offered
14.13.4 SWOT Analysis
14.13.5 The SNS View
14.14 Siemens Healthineers AG
14.14.1Company Overview
14.14.2 Financials
14.14.3 Product/Services Offered
14.14.4 SWOT Analysis
14.14.5 The SNS View
14.15 BioLytical Laboratories Inc.
14.15.1Company Overview
14.15.2 Financials
14.15.3 Product/Services Offered
14.15.4 SWOT Analysis
14.15.5 The SNS View
15. Competitive Landscape
15. Competitive Landscape
15.1 Competitive Bench marking
15.2 Market Share Analysis
15.3 Recent Developments
15.3.1 Industry News
15.3.2 Company News
15.3.3 Mergers & Acquisitions
16. USE Cases and Best Practices
17. Conclusion
An accurate research report requires proper strategizing as well as implementation. There are multiple factors involved in the completion of good and accurate research report and selecting the best methodology to compete the research is the toughest part. Since the research reports we provide play a crucial role in any company’s decision-making process, therefore we at SNS Insider always believe that we should choose the best method which gives us results closer to reality. This allows us to reach at a stage wherein we can provide our clients best and accurate investment to output ratio.
Each report that we prepare takes a timeframe of 350-400 business hours for production. Starting from the selection of titles through a couple of in-depth brain storming session to the final QC process before uploading our titles on our website we dedicate around 350 working hours. The titles are selected based on their current market cap and the foreseen CAGR and growth.
The 5 steps process:
Step 1: Secondary Research:
Secondary Research or Desk Research is as the name suggests is a research process wherein, we collect data through the readily available information. In this process we use various paid and unpaid databases which our team has access to and gather data through the same. This includes examining of listed companies’ annual reports, Journals, SEC filling etc. Apart from this our team has access to various associations across the globe across different industries. Lastly, we have exchange relationships with various university as well as individual libraries.
Step 2: Primary Research
When we talk about primary research, it is a type of study in which the researchers collect relevant data samples directly, rather than relying on previously collected data. This type of research is focused on gaining content specific facts that can be sued to solve specific problems. Since the collected data is fresh and first hand therefore it makes the study more accurate and genuine.
We at SNS Insider have divided Primary Research into 2 parts.
Part 1 wherein we interview the KOLs of major players as well as the upcoming ones across various geographic regions. This allows us to have their view over the market scenario and acts as an important tool to come closer to the accurate market numbers. As many as 45 paid and unpaid primary interviews are taken from both the demand and supply side of the industry to make sure we land at an accurate judgement and analysis of the market.
This step involves the triangulation of data wherein our team analyses the interview transcripts, online survey responses and observation of on filed participants. The below mentioned chart should give a better understanding of the part 1 of the primary interview.
Part 2: In this part of primary research the data collected via secondary research and the part 1 of the primary research is validated with the interviews from individual consultants and subject matter experts.
Consultants are those set of people who have at least 12 years of experience and expertise within the industry whereas Subject Matter Experts are those with at least 15 years of experience behind their back within the same space. The data with the help of two main processes i.e., FGDs (Focused Group Discussions) and IDs (Individual Discussions). This gives us a 3rd party nonbiased primary view of the market scenario making it a more dependable one while collation of the data pointers.
Step 3: Data Bank Validation
Once all the information is collected via primary and secondary sources, we run that information for data validation. At our intelligence centre our research heads track a lot of information related to the market which includes the quarterly reports, the daily stock prices, and other relevant information. Our data bank server gets updated every fortnight and that is how the information which we collected using our primary and secondary information is revalidated in real time.
Step 4: QA/QC Process
After all the data collection and validation our team does a final level of quality check and quality assurance to get rid of any unwanted or undesired mistakes. This might include but not limited to getting rid of the any typos, duplication of numbers or missing of any important information. The people involved in this process include technical content writers, research heads and graphics people. Once this process is completed the title gets uploader on our platform for our clients to read it.
Step 5: Final QC/QA Process:
This is the last process and comes when the client has ordered the study. In this process a final QA/QC is done before the study is emailed to the client. Since we believe in giving our clients a good experience of our research studies, therefore, to make sure that we do not lack at our end in any way humanly possible we do a final round of quality check and then dispatch the study to the client.
The Single-cell Omics Market size was estimated USD 1.5 billion in 2022 and is expected to reach USD 4.9 billion by 2030 at a CAGR of 16.2% during the forecast period of 2023-2030.
The Disposable Medical Gloves Market was valued at USD 12,290 Mn in 2022 and is expected to reach USD 16,309 Mn by 2030 and grow at a CAGR of 3.6% during the forecasted period 2023-2030.
The Biohacking Market size was valued at USD 22.17 billion in 2022 and is expected to reach at USD 90.36 billion by 2030, and grow at a CAGR of 19.2% over the forecast period of 2023-2030.
The Sleep Disorder Treatment Market size was valued at US$ 9.2 billion in 2022 and is projected to reach US$ 18 billion by 2030, with a growing CAGR of 8.7% over the forecast period 2023-2030.
The Immunohistochemistry Market size was estimated USD 2.4 billion in 2022 and is expected to reach USD 3.7 billion by 2030 at a CAGR of 5.9% during the forecast period of 2023-2030.
The Healthcare Analytical Testing Services Market Size was valued at USD 12.07 billion in 2022, and is expected to reach USD 24.78 billion by 2030, and grow at a CAGR of 9.4% over the forecast period 2023-2030.
Hi! Click one of our member below to chat on Phone
© 2023 All Rights Reserved by SNS Insider Pvt Ltd
